Tapewire

Nasdaq · USD

GTBP

GT Biopharma, Inc.

Export transactions ↓
Tapewire entity
7878
SEC CIK
0000109657
Parsed reports
53

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 04, 2025 Filed Sep 8, 2025 21:45 UTC
Breen Michael MartinDirector · CEO and Director
GrantOption to purchase Common Stock · Derivative 100,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026890 · ownership.xml · derivative · entry 3

Breen Michael Martin · CIK 0001863633 · Director · CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-08-19

F3 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on January 1, 2026.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC
Breen Michael MartinDirector · CEO and Director
GrantOption to purchase Common Stock · Derivative 100,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026890 · ownership.xml · derivative · entry 2

Breen Michael Martin · CIK 0001863633 · Director · CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-08-19

F2 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on January 1, 2025.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC
Breen Michael MartinDirector · CEO and Director
GrantOption to purchase Common Stock · Derivative 100,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026890 · ownership.xml · derivative · entry 1

Breen Michael Martin · CIK 0001863633 · Director · CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2035-08-19

F1 · derivative.exercise_date: The options are fully vested and exercisable.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC GrantOption to purchase Common Stock · Derivative 31,250 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026893 · ownership.xml · derivative · entry 1

Mun-Gavin David C. · CIK 0002078965 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Common Stock · 31,250 shares

Expires 2035-08-19

F1 · derivative.exercise_date: The options are fully vested and exercisable.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC GrantOption to purchase Common Stock · Derivative 62,500 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026891 · ownership.xml · derivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2035-08-19

F1 · derivative.exercise_date: The options are fully vested and exercisable.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC
URBAN ALAN LOUISChief Financial Officer
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026894 · ownership.xml · derivative · entry 2

URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-08-19

F2 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on January 1, 2026.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC
URBAN ALAN LOUISChief Financial Officer
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026894 · ownership.xml · derivative · entry 1

URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-08-19

F1 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on January 1, 2025.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:45 UTC GrantOption to purchase Common Stock · Derivative 31,250 $0.00 Strike: $1.33 $0.00
Disclosure

SEC source: 0001641172-25-026892 · ownership.xml · derivative · entry 1

Kramer Hilary · CIK 0002071192 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Common Stock · 31,250 shares

Expires 2035-08-19

F1 · derivative.exercise_date: The options are fully vested and exercisable.

Read SEC document
October 17, 2024 Filed Oct 22, 2024 01:13 UTC
URBAN ALAN LOUISChief Financial Officer
GrantOption to purchase Common Stock · Derivative 23,335 $0.00 Strike: $2.11 $0.00
Disclosure

SEC source: 0001493152-24-041855 · ownership.xml · derivative · entry 1

URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,335

Underlying: Common Stock · 23,335 shares

Expires 2034-10-16

F1 · derivative.exercise_date: 1/36th of the shares vest on the monthly anniversary of June 3, 2024 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant without Cause (as defined in the reporting person's Employment Agreement dated June 7, 2024), resignation by the reporting person for Good Reason (as defined in the reporting person's Employment Agreement dated June 7, 2024), or in the event of a Change in Control (as defined in the registrant's 2022 Omnibus Incentive Plan).

Read SEC document
August 11, 2023 Filed Aug 15, 2023 23:29 UTC
Breen Michael MartinDirector · Executive Chairman/Interim CEO
GrantCommon Stock 200,000 $0.29 $57,400.00
Disclosure

SEC source: 0001493152-23-029061 · ownership.xml · nonDerivative · entry 1

Breen Michael Martin · CIK 0001863633 · Director · Executive Chairman/Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 856,218

Read SEC document
August 11, 2023 Filed Aug 15, 2023 23:26 UTC
Ohri ManuCFO & Secretary
OtherCommon Stock 200,000 $0.29 $57,400.00
Disclosure

SEC source: 0001493152-23-029059 · ownership.xml · nonDerivative · entry 3

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · By Anarjay Concepts, Inc.

Disclosed balance after: 300,000

F1 · kind: The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 23:26 UTC
Ohri ManuCFO & Secretary
OtherCommon Stock 200,000 $0.29 $57,400.00
Disclosure

SEC source: 0001493152-23-029059 · ownership.xml · nonDerivative · entry 2

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 23:26 UTC
Ohri ManuCFO & Secretary
GrantCommon Stock 200,000 $0.29 $57,400.00
Disclosure

SEC source: 0001493152-23-029059 · ownership.xml · nonDerivative · entry 1

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Read SEC document
June 16, 2023 Filed Jun 21, 2023 23:58 UTC GrantOption to purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.35 $0.00
Disclosure

SEC source: 0001493152-23-022059 · ownership.xml · derivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-06-15

F1 · derivative.exercise_date: 1/12th of the shares vest on the monthly anniversary of May 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

Read SEC document
April 11, 2023 Filed Apr 11, 2023 22:59 UTC
Breen Michael MartinDirector · Executive Chairman/Interim CEO
PurchaseCommon Stock 50,000 $0.50 $25,000.00
Disclosure

SEC source: 0001493152-23-011888 · ownership.xml · nonDerivative · entry 1

Breen Michael Martin · CIK 0001863633 · Director · Executive Chairman/Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 656,218

Read SEC document
April 06, 2023 Filed Apr 10, 2023 21:26 UTC
Ohri ManuCFO & Secretary
PurchaseCommon Stock 50,000 $0.50 $25,000.00
Disclosure

SEC source: 0001493152-23-011772 · ownership.xml · nonDerivative · entry 1

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ohri Family Revocable Trust U/A Dated 02/10/2020

Disclosed balance after: 50,000

Read SEC document
January 27, 2023 Filed Feb 1, 2023 11:05 UTC
Breen Michael MartinDirector · Exec Chairman and Interim CEO
GrantOption to purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001493152-23-003230 · ownership.xml · derivative · entry 1

Breen Michael Martin · CIK 0001863633 · Director · Exec Chairman and Interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct, and the reporting person is involuntarily terminated by the registrant.

Read SEC document
January 27, 2023 Filed Feb 1, 2023 11:02 UTC
Ohri ManuChief Financial Officer
GrantOption to purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001493152-23-003227 · ownership.xml · derivative · entry 1

Ohri Manu · CIK 0001424683 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.

Read SEC document
January 27, 2023 Filed Feb 1, 2023 11:02 UTC GrantOption to purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001493152-23-003226 · ownership.xml · derivative · entry 1

SHROTRIYA RAJESH C MD · CIK 0001193918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

Read SEC document
January 27, 2023 Filed Feb 1, 2023 11:01 UTC
Wendel BruceDirector
GrantOption to purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001493152-23-003224 · ownership.xml · derivative · entry 1

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:48 UTC
Breen Michael MartinDirector · Exec. Chair. and Interim CEO
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019876 · ownership.xml · derivative · entry 2

Breen Michael Martin · CIK 0001863633 · Director · Exec. Chair. and Interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:48 UTC
Breen Michael MartinDirector · Exec. Chair. and Interim CEO
GrantCommon Stock 278,058 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-019876 · ownership.xml · nonDerivative · entry 1

Breen Michael Martin · CIK 0001863633 · Director · Exec. Chair. and Interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 606,218

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:46 UTC GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019874 · ownership.xml · derivative · entry 1

URBAN ALAN LOUIS · CIK 0001534376 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

F1 · derivative.exercise_date: 1/4th of the shares vest on the date of grant and on each of September 9, 2022, December 9, 2022 and March 9, 2023.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:46 UTC GrantOption to purchase Common Stock · Derivative 361,476 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019875 · ownership.xml · derivative · entry 3

SHROTRIYA RAJESH C MD · CIK 0001193918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,476

Underlying: Common Stock · 361,476 shares

Expires 2032-07-14

F2 · derivative.exercise_date: 240,984 shares vest on the date of grant and 120,492 shares vest on January 13, 2023.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:46 UTC GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019875 · ownership.xml · derivative · entry 2

SHROTRIYA RAJESH C MD · CIK 0001193918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

F1 · derivative.exercise_date: 1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:46 UTC GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019875 · ownership.xml · derivative · entry 1

SHROTRIYA RAJESH C MD · CIK 0001193918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:44 UTC
Berk GregoryPres. of R&D, CMO
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019873 · ownership.xml · derivative · entry 1

Berk Gregory · CIK 0001306870 · Pres. of R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:42 UTC
Wendel BruceDirector
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019871 · ownership.xml · derivative · entry 2

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

F1 · derivative.exercise_date: 1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:42 UTC
Wendel BruceDirector
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019871 · ownership.xml · derivative · entry 1

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-14

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:44 UTC
Ohri ManuCFO & Secretary
GrantOption to purchase Common Stock · Derivative 200,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001493152-22-019872 · ownership.xml · derivative · entry 4

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-07-14

F2 · derivative.exercise_date: 66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:44 UTC
Ohri ManuCFO & Secretary
OtherCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-019872 · ownership.xml · nonDerivative · entry 3

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · By Anarjay Concepts, Inc.

Disclosed balance after: 100,000

F1 · kind: The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:44 UTC
Ohri ManuCFO & Secretary
OtherCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-019872 · ownership.xml · nonDerivative · entry 2

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:44 UTC
Ohri ManuCFO & Secretary
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-019872 · ownership.xml · nonDerivative · entry 1

Ohri Manu · CIK 0001424683 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Read SEC document
December 31, 2021 Filed Feb 14, 2022 21:09 UTC
Choy GavinActing Chief Financial Officer
GrantOption to purchase Common Stock · Derivative 227,500 $0.00 Strike: $3.05 $0.00
Disclosure

SEC source: 0001654954-22-001631 · section16.xml · derivative · entry 1

Choy Gavin · CIK 0001905561 · Acting Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,500

Underlying: Common Stock · 227,500 shares

Expires 2031-12-31

F1 · derivative.exercise_date: 33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control.

Read SEC document
February 25, 2021 Filed Nov 12, 2021 17:01 UTC Conversion10% Senior Convertible Debenture · Derivative 30,000 $0.00 Strike: $3.40 $0.00
Disclosure

SEC source: 0001654954-21-012057 · section16.xml · derivative · entry 6

Breen Michael Martin · CIK 0001863633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,859 shares

Expires 2021-06-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2021 Filed Nov 12, 2021 17:01 UTC Conversion10% Senior Convertible Debenture · Derivative 100,000 $0.00 Strike: $3.40 $0.00
Disclosure

SEC source: 0001654954-21-012057 · section16.xml · derivative · entry 5

Breen Michael Martin · CIK 0001863633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,243 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.expiration_date: While the maturity date of the Debenture was September 7, 2019, the Registrant did not repay the Debenture on the maturity date and the Debenture remained outstanding until converted.

Read SEC document
February 25, 2021 Filed Nov 12, 2021 17:01 UTC ConversionCommon Stock 9,859 $3.40 $33,520.60
Disclosure

SEC source: 0001654954-21-012057 · section16.xml · nonDerivative · entry 3

Breen Michael Martin · CIK 0001863633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,160

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2021 Filed Nov 12, 2021 17:01 UTC ConversionCommon Stock 40,243 $3.40 $136,826.20
Disclosure

SEC source: 0001654954-21-012057 · section16.xml · nonDerivative · entry 2

Breen Michael Martin · CIK 0001863633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2021 Filed Oct 7, 2021 18:47 UTC
Wendel BruceDirector
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $6.33 $0.00
Disclosure

SEC source: 0001654954-21-010887 · section16.xml · derivative · entry 5

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-15

F2 · derivative.exercise_date: 1/3rd of the shares vest on February 16, 2021, 2022, and 2023.

Read SEC document
February 16, 2021 Filed Oct 7, 2021 18:47 UTC
Wendel BruceDirector
GrantCommon Stock 347,572 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-010887 · section16.xml · nonDerivative · entry 4

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,655

F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022.

Read SEC document
February 16, 2021 Filed Nov 12, 2021 17:01 UTC GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $6.33 $0.00
Disclosure

SEC source: 0001654954-21-012057 · section16.xml · derivative · entry 4

Breen Michael Martin · CIK 0001863633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-15

F2 · derivative.exercise_date: 1/3rd of the shares vest on February 16, 2021, 2022 and 2023.

Read SEC document
February 16, 2021 Filed Nov 12, 2021 17:01 UTC GrantCommon Stock 278,058 $0.00 $0.00
Disclosure

SEC source: 0001654954-21-012057 · section16.xml · nonDerivative · entry 1

Breen Michael Martin · CIK 0001863633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,058

F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on January 13, 2021, 2022 and 2023.

Read SEC document
February 16, 2021 Filed Feb 14, 2022 22:10 UTC
Berk GregoryDirector
GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $6.33 $0.00
Disclosure

SEC source: 0001654954-22-001643 · section16.xml · derivative · entry 2

Berk Gregory · CIK 0001306870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-15

F2 · derivative.exercise_date: Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023.

Read SEC document
February 16, 2021 Filed Feb 14, 2022 22:10 UTC
Berk GregoryDirector
GrantCommon Stock 278,058 $0.00 $0.00
Disclosure

SEC source: 0001654954-22-001643 · section16.xml · nonDerivative · entry 1

Berk Gregory · CIK 0001306870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,058

F1 · shares: Represents a grant of shares of restricted stock ("RSAs") in connection with the reporting person's services as a director. 1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022. The reporting person resigned as a director on April 23, 2021.

Read SEC document
February 16, 2021 Filed Feb 14, 2022 21:13 UTC GrantOption to purchase Common Stock · Derivative 50,000 $0.00 Strike: $6.33 $0.00
Disclosure

SEC source: 0001654954-22-001635 · section16.xml · derivative · entry 1

SHROTRIYA RAJESH C MD · CIK 0001193918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-15

F1 · derivative.exercise_date: 1/3rd of the shares vest on February 16, 2021, 2022 and 2023.

Read SEC document
December 22, 2020 Filed Dec 23, 2020 21:24 UTC
Weldon Steven WFormer Officer and Director
SaleCommon Stock 47,978 $0.40 $19,191.20
Disclosure

SEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 4

Weldon Steven W · CIK 0001356710 · Former Officer and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,720,000

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.

Read SEC document
December 22, 2020 Filed Oct 7, 2021 18:47 UTC
Wendel BruceDirector
PurchaseCommon Stock 441 $8.73 $3,849.93
Disclosure

SEC source: 0001654954-21-010887 · section16.xml · nonDerivative · entry 3

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,083

Read SEC document
December 22, 2020 Filed Oct 7, 2021 18:47 UTC
Wendel BruceDirector
PurchaseCommon Stock 1,374 $8.87 $12,187.38
Disclosure

SEC source: 0001654954-21-010887 · section16.xml · nonDerivative · entry 2

Wendel Bruce · CIK 0001364846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,642

Read SEC document
December 21, 2020 Filed Dec 23, 2020 21:24 UTC
Weldon Steven WFormer Officer and Director
SaleCommon Stock 35,722 $0.34 $12,145.48
Disclosure

SEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 3

Weldon Steven W · CIK 0001356710 · Former Officer and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,767,978

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.

Read SEC document
December 21, 2020 Filed Dec 23, 2020 21:24 UTC
Weldon Steven WFormer Officer and Director
SaleCommon Stock 50,000 $0.33 $16,500.00
Disclosure

SEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 2

Weldon Steven W · CIK 0001356710 · Former Officer and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,803,700

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.